Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation. We report on innovative drug introductions and promising pipeline candidates from Big Pharma and smaller players, as well as relevant clinical trial trends.
The publication also covers promising technological developments relevant to the biotech, biopharma and pharma industries, including advances in artificial intelligence, genomic/proteomic sequencing and microscopy. Other areas of focus include orphan drugs, drug advances for oncology, neurological disease and infectious disease including vaccines and other therapies for COVID-19.
Our content includes staff-written articles as well as contributed content from experts.
The publication serves the pharmaceutical, biopharmaceutical and biotechnology industries, contract research organizations, government laboratories, universities, hospitals, medical centers and others within the life science marketplace.
Our readers include informatics specialists, staff scientists, research scientists, corporate and lab management and scientists conducting and leading research within the field.
Sign up for our free e-newsletter to stay up to date with the top current stories of the drug discovery and development industry.
Drug Discovery and Development is a MassDevice-affiliated pharmaceutical industry news website, owned by Cleveland-based WTWH Media. We stand by journalistic ethics to provide the most up-to-date, accurate and fairly reported information for our readers.
Meet the Team
Brian is an experienced journalist with more than fifteen years’ experience covering an array of technologies including medical devices, artificial intelligence and cybersecurity. He has held a variety of senior editorial roles over the past decade at Penton and UBM (both now Informa). Multilingual, Brian has an M.A. degree in German from the University of Oklahoma.
Executive Editor, Life Sciences
A professional journalist of 18 years, Chris Newmarker is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He presently manages WTWH Media life science news websites and publications including MassDevice, Medical Design & Outsourcing and more. Mr. Newmarker holds bachelor’s degrees in journalism and political science from Ohio State University.
Assistant Editor, Life Sciences
Sean Whooley is a reporter who traded in the high school sports beat for the medical device beat in August 2019. He spent time covering sports in Twin Falls, Idaho, before returning to his native Massachusetts to report on high school athletics at The Eagle-Tribune. He earned a bachelor’s degree in journalism from the University of Maryland, College Park.
Mary Ann Cooke
Vice President, Life Sciences
Mary Ann Cooke has more than 25 years of life science sales, marketing and education experience. Prior to joining Medical Design & Outsourcing, she worked for U.S. Surgical, and Abbott Diagnostics in multiple positions. During her tenure at U.S. Surgical she worked in a variety of positions including Senior Director of Centers of Excellence where she managed 40 major medical centers that received funding from U.S. Surgical for surgeon and resident training, product development, journal publications, education grants, and development of new technology. Ms. Cooke holds a Bachelor of Science from Ball State University.
Regional Sales Manager
Brian Toole has 30 years of experience in business-to-business marketing. Prior to joining WTWH Media, he worked at Cahners, Reed, UBM and Informa. He earned his bachelor’s degree from the University of Delaware. Before leaving this world, he would truly like to see the Philadelphia Flyers win the Stanley Cup one more time (1974 was the last one).
For a full company directory, please visit the contact page for our parent company WTWH Media.